Document Detail


Comparative pharmacoscintigraphic and pharmacokinetic evaluation of two new formulations of inhaled insulin in type 1 diabetic patients.
MedLine Citation:
PMID:  21983605     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
In this open, single-dose study, we compared the lung deposition and bioavailability of two newly developed insulin formulations for pulmonary delivery. Twelve type 1 diabetic patients were administered the two insulin products (2U/kgb.w.), which had been radiolabelled with (99m)Tc. The formulations were either microparticles of insulin without excipients (F1) or lipid-coated insulin microparticles (F2). Lung deposition was assessed by γ-scintigraphy imaging performed immediately after administration. Bioavailability was evaluated by quantifying serum insulin levels over a period of 6h. Lung deposition was found to be 50±9% and 24±8% for the F1 and F2 formulations, respectively. The insulin AUC(0-360) ratio of F1/F2 was 188%, which was consistent with scintigraphic imaging. The concordance between imaging and biological results suggests that the lower bioavailability of F2 is due to its lower lung deposition and not to a reduced absorption into the blood stream. Additional in vitro experiments indicated that the lower performance of F2 was most probably related to a lower disaggregation efficiency of the powder when administered at a sub-optimal flow rate. The two formulations showed interesting pharmacokinetic profiles (T(max) of 26 and 16min for F1 and F2, respectively) that mimic the physiological insulin secretion pattern. The bioavailability of the developed formulations was within the range of other DPI insulin formulations that have reached the final stages of clinical development.
Authors:
F Depreter; A Burniat; D Blocklet; S Lacroix; M Cnop; F Fery; N Van Aelst; G Pilcer; M Deleers; S Goldman; K Amighi
Related Documents :
1292245 - Amelioration of diabetic microalbuminuria and lipid peroxidation by captopril.
7555505 - Prevalence and associated features of albuminuria in koreans with niddm.
9453015 - Effect of octreotide, captopril or insulin on renal changes and uae in long-term experi...
3781805 - Urinary excretion of xanthurenic acid and zinc in diabetes: (3). occurrence of xanthure...
19180065 - Prevention of weight gain in adult patients with type 2 diabetes treated with pioglitaz...
413505 - Experience with low-dose insulin infusion in diabetic ketoacidosis and diabetic hyperos...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-9-29
Journal Detail:
Title:  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V     Volume:  -     ISSN:  1873-3441     ISO Abbreviation:  -     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-10-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9109778     Medline TA:  Eur J Pharm Biopharm     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011. Published by Elsevier B.V.
Affiliation:
Laboratory of Pharmaceutics and Biopharmaceutics, Université Libre de Bruxelles, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Nanocapsules prepared via nanoprecipitation and emulsification-diffusion methods: Comparative study.
Next Document:  Design space approach in the optimization of the spray-drying process.